Welcome to our dedicated page for SILICON LABORATORIES SEC filings (Ticker: SLAB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on SILICON LABORATORIES's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into SILICON LABORATORIES's regulatory disclosures and financial reporting.
LOWE GREGG A reported acquisition or exercise transactions in this Form 4 filing.
SILICON LABORATORIES INC. director Gregg A. Lowe received a grant of 962 restricted stock units (RSUs), each representing one share of common stock. The RSUs vest in full on the earlier of the first anniversary of the grant date or one day before the next Annual Meeting of Stockholders. Following this award, Lowe directly holds 14,956 shares of common stock.
Luther Sherri R reported acquisition or exercise transactions in this Form 4 filing.
Silicon Laboratories Inc. director Sherri R. Luther received an equity award in the form of restricted stock units. The grant covers 962 RSUs, each convertible into one share of common stock. These RSUs vest in full on the earlier of the first anniversary of the grant date or the day before the next year’s Annual Meeting of Stockholders.
After this award, Luther directly holds 6,701 shares of Silicon Labs common stock. This is a compensation-related grant, not an open-market stock purchase or sale.
Silicon Laboratories Inc. held its Annual Meeting of Stockholders on April 23, 2026. Stockholders elected Class I directors Navdeep S. Sooch and Nina Richardson, each receiving over 26.8 million votes in favor with relatively low opposition and abstentions.
Stockholders also ratified Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending January 2, 2027, with over 29.3 million votes for the proposal. In advisory voting, stockholders approved executive compensation and separately approved amendments to the Company’s 2009 Stock Incentive Plan.
Silicon Laboratories Inc. is asking stockholders to approve a merger with Texas Instruments. If approved, Merger Sub will merge into Silicon Labs and Silicon Labs will become a wholly owned subsidiary of Texas Instruments.
Each outstanding share of Silicon Labs common stock will convert into the right to receive $231.00 in cash, less applicable withholding. The Board unanimously recommends that stockholders vote FOR the Merger Proposal, the Compensation Proposal and the Adjournment Proposal. The Special Meeting is scheduled for April 30, 2026 and the Record Date was March 23, 2026 (32,968,416 shares outstanding as of that date).
Silicon Laboratories Inc Schedule 13G/A: The Vanguard Group filed an amendment reporting zero shares beneficially owned and 0% of Silicon Laboratories Inc common stock. The filing explains an internal realignment effective January 12, 2026 under SEC Release No. 34-39538 that caused certain Vanguard subsidiaries and business divisions to report holdings separately.
The form states Vanguard's subsidiaries continue the same investment strategies previously pursued and that The Vanguard Group, Inc. no longer is deemed to have beneficial ownership of securities held by those entities.
Silicon Laboratories Inc. is asking stockholders to approve a merger under which Texas Instruments will acquire Silicon Labs for $231.00 in cash per share. The Board unanimously approved and recommended the Merger Proposal and Silicon Labs’ financial advisor, Qatalyst Partners, rendered a written fairness opinion dated February 3, 2026.
The transaction requires stockholder approval and regulatory clearances, including filings under the HSR Act and certain foreign antitrust and foreign direct investment reviews. The proxy discloses termination fee mechanics ($259 million payable by Silicon Labs; $499 million payable by Texas Instruments) and states the companies expect to close, subject to approvals and conditions, in the first half of 2027.
Silicon Laboratories Inc. is asking shareholders to vote at a virtual annual meeting on April 23, 2026. Investors will elect two Class I directors, ratify Deloitte & Touche as auditor, cast an advisory vote on 2025 executive pay, and approve amendments to the 2009 Stock Incentive Plan.
The company reports 2025 revenue growth of 34%, describing it as a strong recovery after a 2024 inventory-driven correction. It seeks authorization for an additional 1,400,000 shares under the stock plan, which management estimates would bring total potential equity overhang to about 10.01%. The proxy also explains the 2025 switch from Ernst & Young to Deloitte following a 2023 material weakness in inventory accounting controls, and outlines detailed board independence, committee structure, director compensation and sustainability governance.
FMR LLC filed an amendment to a Schedule 13G reporting beneficial ownership of 697,454.83 shares, representing 2.1% of Silicon Laboratories Inc. common stock. The filing lists sole dispositive power of 697,454.83 shares and indicates ownership of 5% or less of the class. Signatures show authorization by Stephanie J. Brown on behalf of FMR LLC and Abigail P. Johnson, dated 03/05/2026.
Silicon Laboratories’ Chief Accounting Officer Mark D. Mauldin reported routine equity compensation changes. On February 15, 2026, he acquired 3,153 restricted stock units (RSUs) at $0 per share, which will vest in three equal annual installments under the company’s 2009 Stock Incentive Plan.
On February 13, 2026, 356 shares of common stock at $207.27 per share were disposed of to cover taxes upon vesting of a prior award. Following these transactions, he directly beneficially owned 21,930 shares of Silicon Laboratories common stock.